DTC Ad Shows Need for Probe of Decongestants' Effectiveness

Washington Drug Letter
KEYWORDS Capitol Hill / FDA

A recent direct-to-consumer (DTC) ad may indicate that the new active ingredient in many nasal decongestants is no more effective than a placebo, highlighting the need for an FDA investigation, Rep. Henry Waxman (D-Calif.) says.

To View This Article:


Buy This Article Now

Add this article to your cart for $10.00